Researchers found that surprisingly making even small improvements in cardiovascular health, can reduce the risk for developing high blood pressure.

TOP INSIGHT
The risk of heart disease can be reduced and even prevented with the 'Life's Simple 7' program.
The Life's Simple 7 was developed by the American Heart Association to monitor cardiovascular health in US adults and to help demonstrate that small changes can lead to a big impact in improving heart health.
The Life's Simple 7 includes: not smoking; maintaining a healthy weight; eating healthy; being physically active; maintaining healthy blood sugar levels; controlling cholesterol levels and managing blood pressure to reduce the risk of heart attack and stroke.
Compared with whites, African Americans have a greater risk for developing high blood pressure.4 According to the American Heart Association, currently one out of three adults in America has high blood pressure.
Among non-Hispanic blacks, 45 percent of men and nearly half (46.3 percent) of women have high blood pressure.
"We found that even small improvements in cardiovascular health can reduce risk for developing high blood pressure."
Among the study group researchers found:
More than half (50.3 percent) developed high blood pressure.
Eight out of 10 (81.3 percent) who followed only one or none of the healthy behaviors developed high blood pressure compared with only 1 in 10 (11.1 percent) of participants who followed six of the behaviors. None of the participants followed all seven healthy behaviors at the beginning of the study.9
Overall, participants who followed more ideal health behaviors were younger and more likely to be women and to have at least a high school education and a household income of at least $25,000 a year.
Booth said that more research is needed to better understand why African Americans remain a population particularly vulnerable to high blood pressure, but that the Life's Simple 7 program offers an opportunity to intervene and reduce their risk for additional heart health complications.
Co-authors are: John N. Booth III, MS; Paul Muntner, PhD Marwah Abdalla, MD, MPH; Rikki Tanner, PhD; Keith Diaz, PhD; Samantha Bromfield, PhD; Gabriel Tajeu, PhD; Adolfo Correa, MD, PhD; Mario Sims, PhD; Gbenga Ogedegbe, MD; Adam Bress, PharmD; Tanya Spruill, PhD; and Daichi Shimbo, MD;. Author disclosures are on the manuscript.
Source-Eurekalert
MEDINDIA




Email




